Analyze Diet
Equine veterinary journal2021; 53(6); 1088-1090; doi: 10.1111/evj.13509

Clinical insights: Equine herpesvirus myeloencephalopathy: The conundrum of vaccination in performance and leisure horses.

Abstract: No abstract available
Publication Date: 2021-10-07 PubMed ID: 34611933DOI: 10.1111/evj.13509Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Editorial

Cite This Article

APA
Kydd JH. (2021). Clinical insights: Equine herpesvirus myeloencephalopathy: The conundrum of vaccination in performance and leisure horses. Equine Vet J, 53(6), 1088-1090. https://doi.org/10.1111/evj.13509

Publication

ISSN: 2042-3306
NlmUniqueID: 0173320
Country: United States
Language: English
Volume: 53
Issue: 6
Pages: 1088-1090

Researcher Affiliations

Kydd, Julia H
  • School of Veterinary Medicine and Science, University of Nottingham, Loughborough, UK.

MeSH Terms

  • Animals
  • Herpesviridae Infections / veterinary
  • Herpesvirus 1, Equid
  • Horse Diseases / prevention & control
  • Horses
  • Leisure Activities
  • Vaccination / veterinary
  • Varicellovirus

References

This article includes 13 references
  1. Pusterla N, Soboll Hussey G. Equine herpesvirus 1 myeloencephalopathy. Vet Clin North Am Equine Pract 2014;30:489-506.
  2. Goehring LS, Van Winden SC, Van Maanen C, Sloet van Oldruitemnborgh-Oosterbaan MM. Equine herpesvirus type 1-associated myeloencephalopathy in The Netherlands: a four-year retrospective study (1999-2003). J Vet Intern Med 2006;20:601-7.
  3. . Equine herpesvirus-1 - neurological form. 2021.
  4. Göhring L, Feige K, Sloet M, De Clercq D, Gerber V, Korbacska-Kutasi O. European College of Equine Internal Medicine (ECEIM) guidelines for dealing with returning horses from EHV-1 outbreaks and Update on equine herpesvirus-1 therapy. 2021.
  5. . Submission of EHV-1 related information through updated FEI HorseApp. 2021.
  6. Available from: https://online.flippingbook.com/view/224911474/ Accessed September 1, 2021.
  7. Lunn DP, Davis-Poynter N, Flaminio MJBF, Horohov DW, Osterrieder K, Pusterla N. Equine herpesvirus-1 consensus statement. J Vet Intern Med 2009;23(3):450-61.
  8. Allen GP. Risk factors for development of neurologic disease after experimental exposure to equine herpesvirus-1 in horses. Am J Vet Res 2008;69:1595-600.
  9. Kydd JH, Wattrang E, Hannant D. Pre-infection frequencies of equine herpesvirus-1 specific, cytotoxic T lymphocytes correlate with protection against abortion following experimental infection of pregnant mares. Vet Immunol Immunopathol 2003;96(3-4):207-17.
  10. Goehring L, Wagner B, Bigbie R, Hussey SB, Rao S, Morley PS. Control of EHV-1 viremia and nasal shedding by commercial vaccines. Vaccine 2010;28:5203-11.
  11. Blocken B, Malizia F, van Druenen T, Marchal T. Towards aerodynamically equivalent COVID19 1.5 m social distancing for walking and running. 2020.
  12. Edington N, Bridges CG, Patel JR. Endothelial cell infection and thrombosis in paralysis caused by equid herpesvirus-1: equine stroke. Arch Virol 1986;90(1-2):111-24.
    doi: 10.1007/bf01314149google scholar: lookup
  13. Traub-Dargatz JL, Pelzel-McCluskey AM, Creekmore LH, Geiser-Novotny S, Kasari TR, Wiedenheft AM. Case-control study of a multistate equine herpesvirus myeloencephalopathy outbreak. J Vet Intern Med 2013;27(2):339-46.
    doi: 10.1111/jvim.12051google scholar: lookup

Citations

This article has been cited 0 times.